CytRx Corp. 11726 San Vicente Blvd Los Angeles, CA 90049 Phone: 310-826-5648 Fax: 310-826-6139 Re: Investment Banking Agreement with Legend Securities, Inc. Dear Mr.Kriegsman,Investment Banking Agreement • March 13th, 2012 • Cytrx Corp • Biological products, (no disgnostic substances) • New York
Contract Type FiledMarch 13th, 2012 Company Industry JurisdictionThis letter (the “Agreement”) shall confirm the engagement of Legend Securities, Inc., (“Legend”) by CytRx Corporation (the “Company” and collectively the “Parties” ) for purposes of providing, on a non-exclusive basis, investor awareness and business advisory services as set forth below in consideration for the fees and compensation described hereinafter:
EMPLOYMENT AGREEMENTEmployment Agreement • March 13th, 2012 • Cytrx Corp • Biological products, (no disgnostic substances) • California
Contract Type FiledMarch 13th, 2012 Company Industry JurisdictionThis Employment Agreement (this “Agreement”) is made and entered into as of January 1, 2012 (the “Effective Date”) by and between CytRx Corporation, a Delaware corporation (“Employer”), and Benjamin S. Levin, an individual and resident of the State of California (“Employee”).
THIRD AMENDMENT TO THIRD AMENDEDEmployment Agreement • March 13th, 2012 • Cytrx Corp • Biological products, (no disgnostic substances)
Contract Type FiledMarch 13th, 2012 Company IndustryThis Third Amendment (this “Amendment”) is entered into on January 1, 2012, between CytRx Corporation, a Delaware corporation (“Employer”), and Steven A. Kriegsman (“Employee”), in order to amend that certain Third Amended and Restated Employment Agreement, made as of May 17, 2005 (the “Agreement”), between Employer and Employee, as follows:
EMPLOYMENT AGREEMENTEmployment Agreement • March 13th, 2012 • Cytrx Corp • Biological products, (no disgnostic substances) • California
Contract Type FiledMarch 13th, 2012 Company Industry JurisdictionThis Employment Agreement (this “Agreement”) is made and entered into as of January 1, 2012 (the “Effective Date”) by and between CytRx Corporation, a Delaware corporation (“Employer”), and Daniel Levitt, M.D., Ph.D., an individual and resident of the State of California (“Employee”).